CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

MDWDMediWound Ltd.

NASDAQ · Medicinal Chemicals & Botanical Products
Last close $13.77 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryMedicinal Chemicals & Botanical Products
RECENT INSIDER TRADES
  • 2026-09-02 · Rubinstein Samuel (Director) · BUY
  • 2026-09-02 · Rubinstein Samuel (Director) · SELL
  • 2026-08-28 · Hess Shmuel (COO & Chief Commercial Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders88
Shares held6,652,994
Value$89.32M
Percent of shares outstanding51.83%
As of quarter end2026-06-30
RECENT NEWS
  • MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
  • MediWound value trial looms as catalyst at H.C. Wainwright
  • DSMB recommends MediWound EscharEx Phase III study continue
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS